Reduced Activation of Phosphatidylinositol-3 Kinase and Increased Serine 636 Phosphorylation of Insulin Receptor Substrate-1 in Primary Culture of Skeletal Muscle Cells From Patients With Type 2 Diabetes

Reduced Activation of Phosphatidylinositol-3 Kinase and Increased Serine 636 Phosphorylation of Insulin Receptor Substrate-1 in Primary Culture of Skeletal Muscle Cells From Patients With Type 2 Diabetes Karim Bouzakri 1 , Marina Roques 1 , Philippe Gual 2 , Sophie Espinosa 1 , Fitsum Guebre-Egziabh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2003-06, Vol.52 (6), p.1319-1325
Hauptverfasser: BOUZAKRI, Karim, ROQUES, Marina, GUAL, Philippe, ESPINOSA, Sophie, GUEBRE-EGZIABHER, Fitsum, RIOU, Jean-Paul, LAVILLE, Martine, LE MARCHAND-BRUSTEL, Yannick, TANTI, Jean-Francois, VIDAL, Hubert
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1325
container_issue 6
container_start_page 1319
container_title Diabetes (New York, N.Y.)
container_volume 52
creator BOUZAKRI, Karim
ROQUES, Marina
GUAL, Philippe
ESPINOSA, Sophie
GUEBRE-EGZIABHER, Fitsum
RIOU, Jean-Paul
LAVILLE, Martine
LE MARCHAND-BRUSTEL, Yannick
TANTI, Jean-Francois
VIDAL, Hubert
description Reduced Activation of Phosphatidylinositol-3 Kinase and Increased Serine 636 Phosphorylation of Insulin Receptor Substrate-1 in Primary Culture of Skeletal Muscle Cells From Patients With Type 2 Diabetes Karim Bouzakri 1 , Marina Roques 1 , Philippe Gual 2 , Sophie Espinosa 1 , Fitsum Guebre-Egziabher 1 , Jean-Paul Riou 1 3 , Martine Laville 1 3 , Yannick Le Marchand-Brustel 2 , Jean-François Tanti 2 and Hubert Vidal 1 1 INSERM U449 and CRNHL, IFR 62, R. Laennec Medical Faculty, Lyon, France 2 INSERM U568, Medical Faculty, Nice, France 3 Department of Endocrinology, Diabetology and Nutrition, E. Herriot Hospital, Lyon, France Abstract To understand better the defects in the proximal steps of insulin signaling during type 2 diabetes, we used differentiated human skeletal muscle cells in primary culture. When compared with cells from control subjects, myotubes established from patients with type 2 diabetes presented the same defects as those previously evidenced in vivo in muscle biopsies, including defective stimulation of phosphatidylinositol (PI) 3-kinase activity, decreased association of PI 3-kinase with insulin receptor substrate (IRS)-1 and reduced IRS-1 tyrosine phosphorylation during insulin stimulation. In contrast to IRS-1, the signaling through IRS-2 was not altered. Investigating the causes of the reduced tyrosine phosphorylation of IRS-1, we found a more than twofold increase in the basal phosphorylation of IRS-1 on serine 636 in myotubes from patients with diabetes. Concomitantly, there was a higher basal mitogen-activated protein kinase (MAPK) activity in these cells, and inhibition of the MAPKs with PD98059 strongly reduced the level of serine 636 phosphorylation. These results suggest that IRS-1 phosphorylation on serine 636 might be involved in the reduced phosphorylation of IRS-1 on tyrosine and in the subsequent alteration of insulin-induced PI 3-kinase activation. Moreover, increased MAPK activity seems to play a role in the phosphorylation of IRS-1 on serine residue in human muscle cells. Footnotes Address correspondence and reprint requests to Dr. Marina Roques, INSERM U449, Faculté de Médecine RTH Laennec, F-69370 Lyon Cedex 08, France. E-mail: roques{at}laennec.univ-lyon1.fr . Received for publication 1 August 2002 and accepted in revised form 19 February 2003. K.B. and M.R. contributed equally to this work. ERK, extracellular signal-related kinase; IRS, insulin receptor substrate; MAPK, mitogen-activated protein kinase; PI, phospha
doi_str_mv 10.2337/diabetes.52.6.1319
format Article
fullrecord <record><control><sourceid>gale_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04496821v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A182921905</galeid><sourcerecordid>A182921905</sourcerecordid><originalsourceid>FETCH-LOGICAL-c619t-62b8d5ccf1d0092506a9390932597efae52570974b387995ae70bae468d07363</originalsourceid><addsrcrecordid>eNptku1qFDEYhQdRbK3egD8kCApFZs3HTGbyc1ntB660tAX9F7KZd3aj2WRNMtW9Rm_KrLu2VJYEQl6ec5KcvEXxkuARZax53xk1gwRxVNMRHxFGxKPikAgmSkabr4-LQ4wJLUkjmoPiWYzfMMY8j6fFAaENrzN4WPy-gm7Q0KGxTuZWJeMd8j26XPi4WuRtt7bG-WiStyVDn4xTEZByHTp3OkDedOgagnGAOOM7mQ9re-d07uKQLdAVaFglH9D1MIspqAQlQbl-GcxShTWaDDYNATaS6-9gISmLPg9RW0ATsDaik-CX6DL7gksRfTFpgW7WK0AUfdjl8Lx40isb4cVuPSpuTj7eTM7K6cXp-WQ8LTUnIpWcztqu1ronHcaC1pirHAUWjNaigV5BTesGi6aasbYRolbQ4JmCircdbhhnR8Xx1nahrFxtry-9MvJsPJWbGq4qwVtKbklm327ZVfA_BohJLk3U-T3KgR-ibBjDosJ1Bl__B37zQ3D5GZISXrUVr6sMlVtorixI43qfg9RzcBCU9Q56k8tj0lJBifhrOtrD59HB0ui9guMHgswk-JXmaohRtqfTh2y5j9XeWpiDzIlPLh7ydMvr4GMM0N9lR7Dc9LP818-yppLLTT9n0atdLMNsCd29ZNfAGXizA1TUyvZBOW3iPVe1NWV5HhXvdp9m5oufJsD9aXuO_QPogw0C</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216484654</pqid></control><display><type>article</type><title>Reduced Activation of Phosphatidylinositol-3 Kinase and Increased Serine 636 Phosphorylation of Insulin Receptor Substrate-1 in Primary Culture of Skeletal Muscle Cells From Patients With Type 2 Diabetes</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>BOUZAKRI, Karim ; ROQUES, Marina ; GUAL, Philippe ; ESPINOSA, Sophie ; GUEBRE-EGZIABHER, Fitsum ; RIOU, Jean-Paul ; LAVILLE, Martine ; LE MARCHAND-BRUSTEL, Yannick ; TANTI, Jean-Francois ; VIDAL, Hubert</creator><creatorcontrib>BOUZAKRI, Karim ; ROQUES, Marina ; GUAL, Philippe ; ESPINOSA, Sophie ; GUEBRE-EGZIABHER, Fitsum ; RIOU, Jean-Paul ; LAVILLE, Martine ; LE MARCHAND-BRUSTEL, Yannick ; TANTI, Jean-Francois ; VIDAL, Hubert</creatorcontrib><description>Reduced Activation of Phosphatidylinositol-3 Kinase and Increased Serine 636 Phosphorylation of Insulin Receptor Substrate-1 in Primary Culture of Skeletal Muscle Cells From Patients With Type 2 Diabetes Karim Bouzakri 1 , Marina Roques 1 , Philippe Gual 2 , Sophie Espinosa 1 , Fitsum Guebre-Egziabher 1 , Jean-Paul Riou 1 3 , Martine Laville 1 3 , Yannick Le Marchand-Brustel 2 , Jean-François Tanti 2 and Hubert Vidal 1 1 INSERM U449 and CRNHL, IFR 62, R. Laennec Medical Faculty, Lyon, France 2 INSERM U568, Medical Faculty, Nice, France 3 Department of Endocrinology, Diabetology and Nutrition, E. Herriot Hospital, Lyon, France Abstract To understand better the defects in the proximal steps of insulin signaling during type 2 diabetes, we used differentiated human skeletal muscle cells in primary culture. When compared with cells from control subjects, myotubes established from patients with type 2 diabetes presented the same defects as those previously evidenced in vivo in muscle biopsies, including defective stimulation of phosphatidylinositol (PI) 3-kinase activity, decreased association of PI 3-kinase with insulin receptor substrate (IRS)-1 and reduced IRS-1 tyrosine phosphorylation during insulin stimulation. In contrast to IRS-1, the signaling through IRS-2 was not altered. Investigating the causes of the reduced tyrosine phosphorylation of IRS-1, we found a more than twofold increase in the basal phosphorylation of IRS-1 on serine 636 in myotubes from patients with diabetes. Concomitantly, there was a higher basal mitogen-activated protein kinase (MAPK) activity in these cells, and inhibition of the MAPKs with PD98059 strongly reduced the level of serine 636 phosphorylation. These results suggest that IRS-1 phosphorylation on serine 636 might be involved in the reduced phosphorylation of IRS-1 on tyrosine and in the subsequent alteration of insulin-induced PI 3-kinase activation. Moreover, increased MAPK activity seems to play a role in the phosphorylation of IRS-1 on serine residue in human muscle cells. Footnotes Address correspondence and reprint requests to Dr. Marina Roques, INSERM U449, Faculté de Médecine RTH Laennec, F-69370 Lyon Cedex 08, France. E-mail: roques{at}laennec.univ-lyon1.fr . Received for publication 1 August 2002 and accepted in revised form 19 February 2003. K.B. and M.R. contributed equally to this work. ERK, extracellular signal-related kinase; IRS, insulin receptor substrate; MAPK, mitogen-activated protein kinase; PI, phosphatidylinositol. DIABETES</description><identifier>ISSN: 0012-1797</identifier><identifier>EISSN: 1939-327X</identifier><identifier>DOI: 10.2337/diabetes.52.6.1319</identifier><identifier>PMID: 12765939</identifier><identifier>CODEN: DIAEAZ</identifier><language>eng</language><publisher>Alexandria, VA: American Diabetes Association</publisher><subject>Antibiotics ; Biological and medical sciences ; Biopsy ; Cells, Cultured ; Chemical properties ; Complications and side effects ; Diabetes ; Diabetes Mellitus, Type 2 ; Diabetes Mellitus, Type 2 - metabolism ; Evaluation ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation, Enzymologic ; Glucose ; Health aspects ; Hexokinase ; Hexokinase - genetics ; Humans ; Insulin ; Insulin Receptor Substrate Proteins ; Insulin receptors ; Insulin resistance ; Kinases ; Life Sciences ; MAP Kinase Signaling System ; MAP Kinase Signaling System - physiology ; Metabolism ; Mitogen-Activated Protein Kinase 1 ; Mitogen-Activated Protein Kinase 1 - metabolism ; Mitogen-Activated Protein Kinase 3 ; Mitogen-Activated Protein Kinases ; Mitogen-Activated Protein Kinases - metabolism ; Muscle, Skeletal ; Muscle, Skeletal - metabolism ; Muscle, Skeletal - pathology ; Muscles ; Musculoskeletal system ; Phosphatidylinositol ; Phosphatidylinositol 3-Kinases ; Phosphatidylinositol 3-Kinases - genetics ; Phosphatidylinositols ; Phosphoproteins ; Phosphoproteins - drug effects ; Phosphoproteins - metabolism ; Phosphorylation ; Phosphoserine ; Phosphoserine - metabolism ; Phosphotyrosine ; Phosphotyrosine - metabolism ; Physiological aspects ; Plasma ; Properties ; Receptor, Insulin ; Receptor, Insulin - drug effects ; Receptor, Insulin - metabolism ; Receptors ; Reference Values ; Risk factors ; RNA, Messenger ; RNA, Messenger - genetics ; Serine ; Skeletal muscle ; Type 2 diabetes</subject><ispartof>Diabetes (New York, N.Y.), 2003-06, Vol.52 (6), p.1319-1325</ispartof><rights>2003 INIST-CNRS</rights><rights>COPYRIGHT 2003 American Diabetes Association</rights><rights>Copyright American Diabetes Association Jun 2003</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c619t-62b8d5ccf1d0092506a9390932597efae52570974b387995ae70bae468d07363</citedby><cites>FETCH-LOGICAL-c619t-62b8d5ccf1d0092506a9390932597efae52570974b387995ae70bae468d07363</cites><orcidid>0000-0003-1782-1318</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14852352$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12765939$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-04496821$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>BOUZAKRI, Karim</creatorcontrib><creatorcontrib>ROQUES, Marina</creatorcontrib><creatorcontrib>GUAL, Philippe</creatorcontrib><creatorcontrib>ESPINOSA, Sophie</creatorcontrib><creatorcontrib>GUEBRE-EGZIABHER, Fitsum</creatorcontrib><creatorcontrib>RIOU, Jean-Paul</creatorcontrib><creatorcontrib>LAVILLE, Martine</creatorcontrib><creatorcontrib>LE MARCHAND-BRUSTEL, Yannick</creatorcontrib><creatorcontrib>TANTI, Jean-Francois</creatorcontrib><creatorcontrib>VIDAL, Hubert</creatorcontrib><title>Reduced Activation of Phosphatidylinositol-3 Kinase and Increased Serine 636 Phosphorylation of Insulin Receptor Substrate-1 in Primary Culture of Skeletal Muscle Cells From Patients With Type 2 Diabetes</title><title>Diabetes (New York, N.Y.)</title><addtitle>Diabetes</addtitle><description>Reduced Activation of Phosphatidylinositol-3 Kinase and Increased Serine 636 Phosphorylation of Insulin Receptor Substrate-1 in Primary Culture of Skeletal Muscle Cells From Patients With Type 2 Diabetes Karim Bouzakri 1 , Marina Roques 1 , Philippe Gual 2 , Sophie Espinosa 1 , Fitsum Guebre-Egziabher 1 , Jean-Paul Riou 1 3 , Martine Laville 1 3 , Yannick Le Marchand-Brustel 2 , Jean-François Tanti 2 and Hubert Vidal 1 1 INSERM U449 and CRNHL, IFR 62, R. Laennec Medical Faculty, Lyon, France 2 INSERM U568, Medical Faculty, Nice, France 3 Department of Endocrinology, Diabetology and Nutrition, E. Herriot Hospital, Lyon, France Abstract To understand better the defects in the proximal steps of insulin signaling during type 2 diabetes, we used differentiated human skeletal muscle cells in primary culture. When compared with cells from control subjects, myotubes established from patients with type 2 diabetes presented the same defects as those previously evidenced in vivo in muscle biopsies, including defective stimulation of phosphatidylinositol (PI) 3-kinase activity, decreased association of PI 3-kinase with insulin receptor substrate (IRS)-1 and reduced IRS-1 tyrosine phosphorylation during insulin stimulation. In contrast to IRS-1, the signaling through IRS-2 was not altered. Investigating the causes of the reduced tyrosine phosphorylation of IRS-1, we found a more than twofold increase in the basal phosphorylation of IRS-1 on serine 636 in myotubes from patients with diabetes. Concomitantly, there was a higher basal mitogen-activated protein kinase (MAPK) activity in these cells, and inhibition of the MAPKs with PD98059 strongly reduced the level of serine 636 phosphorylation. These results suggest that IRS-1 phosphorylation on serine 636 might be involved in the reduced phosphorylation of IRS-1 on tyrosine and in the subsequent alteration of insulin-induced PI 3-kinase activation. Moreover, increased MAPK activity seems to play a role in the phosphorylation of IRS-1 on serine residue in human muscle cells. Footnotes Address correspondence and reprint requests to Dr. Marina Roques, INSERM U449, Faculté de Médecine RTH Laennec, F-69370 Lyon Cedex 08, France. E-mail: roques{at}laennec.univ-lyon1.fr . Received for publication 1 August 2002 and accepted in revised form 19 February 2003. K.B. and M.R. contributed equally to this work. ERK, extracellular signal-related kinase; IRS, insulin receptor substrate; MAPK, mitogen-activated protein kinase; PI, phosphatidylinositol. DIABETES</description><subject>Antibiotics</subject><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Cells, Cultured</subject><subject>Chemical properties</subject><subject>Complications and side effects</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2</subject><subject>Diabetes Mellitus, Type 2 - metabolism</subject><subject>Evaluation</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation, Enzymologic</subject><subject>Glucose</subject><subject>Health aspects</subject><subject>Hexokinase</subject><subject>Hexokinase - genetics</subject><subject>Humans</subject><subject>Insulin</subject><subject>Insulin Receptor Substrate Proteins</subject><subject>Insulin receptors</subject><subject>Insulin resistance</subject><subject>Kinases</subject><subject>Life Sciences</subject><subject>MAP Kinase Signaling System</subject><subject>MAP Kinase Signaling System - physiology</subject><subject>Metabolism</subject><subject>Mitogen-Activated Protein Kinase 1</subject><subject>Mitogen-Activated Protein Kinase 1 - metabolism</subject><subject>Mitogen-Activated Protein Kinase 3</subject><subject>Mitogen-Activated Protein Kinases</subject><subject>Mitogen-Activated Protein Kinases - metabolism</subject><subject>Muscle, Skeletal</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Muscle, Skeletal - pathology</subject><subject>Muscles</subject><subject>Musculoskeletal system</subject><subject>Phosphatidylinositol</subject><subject>Phosphatidylinositol 3-Kinases</subject><subject>Phosphatidylinositol 3-Kinases - genetics</subject><subject>Phosphatidylinositols</subject><subject>Phosphoproteins</subject><subject>Phosphoproteins - drug effects</subject><subject>Phosphoproteins - metabolism</subject><subject>Phosphorylation</subject><subject>Phosphoserine</subject><subject>Phosphoserine - metabolism</subject><subject>Phosphotyrosine</subject><subject>Phosphotyrosine - metabolism</subject><subject>Physiological aspects</subject><subject>Plasma</subject><subject>Properties</subject><subject>Receptor, Insulin</subject><subject>Receptor, Insulin - drug effects</subject><subject>Receptor, Insulin - metabolism</subject><subject>Receptors</subject><subject>Reference Values</subject><subject>Risk factors</subject><subject>RNA, Messenger</subject><subject>RNA, Messenger - genetics</subject><subject>Serine</subject><subject>Skeletal muscle</subject><subject>Type 2 diabetes</subject><issn>0012-1797</issn><issn>1939-327X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptku1qFDEYhQdRbK3egD8kCApFZs3HTGbyc1ntB660tAX9F7KZd3aj2WRNMtW9Rm_KrLu2VJYEQl6ec5KcvEXxkuARZax53xk1gwRxVNMRHxFGxKPikAgmSkabr4-LQ4wJLUkjmoPiWYzfMMY8j6fFAaENrzN4WPy-gm7Q0KGxTuZWJeMd8j26XPi4WuRtt7bG-WiStyVDn4xTEZByHTp3OkDedOgagnGAOOM7mQ9re-d07uKQLdAVaFglH9D1MIspqAQlQbl-GcxShTWaDDYNATaS6-9gISmLPg9RW0ATsDaik-CX6DL7gksRfTFpgW7WK0AUfdjl8Lx40isb4cVuPSpuTj7eTM7K6cXp-WQ8LTUnIpWcztqu1ronHcaC1pirHAUWjNaigV5BTesGi6aasbYRolbQ4JmCircdbhhnR8Xx1nahrFxtry-9MvJsPJWbGq4qwVtKbklm327ZVfA_BohJLk3U-T3KgR-ibBjDosJ1Bl__B37zQ3D5GZISXrUVr6sMlVtorixI43qfg9RzcBCU9Q56k8tj0lJBifhrOtrD59HB0ui9guMHgswk-JXmaohRtqfTh2y5j9XeWpiDzIlPLh7ydMvr4GMM0N9lR7Dc9LP818-yppLLTT9n0atdLMNsCd29ZNfAGXizA1TUyvZBOW3iPVe1NWV5HhXvdp9m5oufJsD9aXuO_QPogw0C</recordid><startdate>20030601</startdate><enddate>20030601</enddate><creator>BOUZAKRI, Karim</creator><creator>ROQUES, Marina</creator><creator>GUAL, Philippe</creator><creator>ESPINOSA, Sophie</creator><creator>GUEBRE-EGZIABHER, Fitsum</creator><creator>RIOU, Jean-Paul</creator><creator>LAVILLE, Martine</creator><creator>LE MARCHAND-BRUSTEL, Yannick</creator><creator>TANTI, Jean-Francois</creator><creator>VIDAL, Hubert</creator><general>American Diabetes Association</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>8GL</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0003-1782-1318</orcidid></search><sort><creationdate>20030601</creationdate><title>Reduced Activation of Phosphatidylinositol-3 Kinase and Increased Serine 636 Phosphorylation of Insulin Receptor Substrate-1 in Primary Culture of Skeletal Muscle Cells From Patients With Type 2 Diabetes</title><author>BOUZAKRI, Karim ; ROQUES, Marina ; GUAL, Philippe ; ESPINOSA, Sophie ; GUEBRE-EGZIABHER, Fitsum ; RIOU, Jean-Paul ; LAVILLE, Martine ; LE MARCHAND-BRUSTEL, Yannick ; TANTI, Jean-Francois ; VIDAL, Hubert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c619t-62b8d5ccf1d0092506a9390932597efae52570974b387995ae70bae468d07363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Antibiotics</topic><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Cells, Cultured</topic><topic>Chemical properties</topic><topic>Complications and side effects</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2</topic><topic>Diabetes Mellitus, Type 2 - metabolism</topic><topic>Evaluation</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation, Enzymologic</topic><topic>Glucose</topic><topic>Health aspects</topic><topic>Hexokinase</topic><topic>Hexokinase - genetics</topic><topic>Humans</topic><topic>Insulin</topic><topic>Insulin Receptor Substrate Proteins</topic><topic>Insulin receptors</topic><topic>Insulin resistance</topic><topic>Kinases</topic><topic>Life Sciences</topic><topic>MAP Kinase Signaling System</topic><topic>MAP Kinase Signaling System - physiology</topic><topic>Metabolism</topic><topic>Mitogen-Activated Protein Kinase 1</topic><topic>Mitogen-Activated Protein Kinase 1 - metabolism</topic><topic>Mitogen-Activated Protein Kinase 3</topic><topic>Mitogen-Activated Protein Kinases</topic><topic>Mitogen-Activated Protein Kinases - metabolism</topic><topic>Muscle, Skeletal</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Muscle, Skeletal - pathology</topic><topic>Muscles</topic><topic>Musculoskeletal system</topic><topic>Phosphatidylinositol</topic><topic>Phosphatidylinositol 3-Kinases</topic><topic>Phosphatidylinositol 3-Kinases - genetics</topic><topic>Phosphatidylinositols</topic><topic>Phosphoproteins</topic><topic>Phosphoproteins - drug effects</topic><topic>Phosphoproteins - metabolism</topic><topic>Phosphorylation</topic><topic>Phosphoserine</topic><topic>Phosphoserine - metabolism</topic><topic>Phosphotyrosine</topic><topic>Phosphotyrosine - metabolism</topic><topic>Physiological aspects</topic><topic>Plasma</topic><topic>Properties</topic><topic>Receptor, Insulin</topic><topic>Receptor, Insulin - drug effects</topic><topic>Receptor, Insulin - metabolism</topic><topic>Receptors</topic><topic>Reference Values</topic><topic>Risk factors</topic><topic>RNA, Messenger</topic><topic>RNA, Messenger - genetics</topic><topic>Serine</topic><topic>Skeletal muscle</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>BOUZAKRI, Karim</creatorcontrib><creatorcontrib>ROQUES, Marina</creatorcontrib><creatorcontrib>GUAL, Philippe</creatorcontrib><creatorcontrib>ESPINOSA, Sophie</creatorcontrib><creatorcontrib>GUEBRE-EGZIABHER, Fitsum</creatorcontrib><creatorcontrib>RIOU, Jean-Paul</creatorcontrib><creatorcontrib>LAVILLE, Martine</creatorcontrib><creatorcontrib>LE MARCHAND-BRUSTEL, Yannick</creatorcontrib><creatorcontrib>TANTI, Jean-Francois</creatorcontrib><creatorcontrib>VIDAL, Hubert</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: High School</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Diabetes (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>BOUZAKRI, Karim</au><au>ROQUES, Marina</au><au>GUAL, Philippe</au><au>ESPINOSA, Sophie</au><au>GUEBRE-EGZIABHER, Fitsum</au><au>RIOU, Jean-Paul</au><au>LAVILLE, Martine</au><au>LE MARCHAND-BRUSTEL, Yannick</au><au>TANTI, Jean-Francois</au><au>VIDAL, Hubert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Reduced Activation of Phosphatidylinositol-3 Kinase and Increased Serine 636 Phosphorylation of Insulin Receptor Substrate-1 in Primary Culture of Skeletal Muscle Cells From Patients With Type 2 Diabetes</atitle><jtitle>Diabetes (New York, N.Y.)</jtitle><addtitle>Diabetes</addtitle><date>2003-06-01</date><risdate>2003</risdate><volume>52</volume><issue>6</issue><spage>1319</spage><epage>1325</epage><pages>1319-1325</pages><issn>0012-1797</issn><eissn>1939-327X</eissn><coden>DIAEAZ</coden><abstract>Reduced Activation of Phosphatidylinositol-3 Kinase and Increased Serine 636 Phosphorylation of Insulin Receptor Substrate-1 in Primary Culture of Skeletal Muscle Cells From Patients With Type 2 Diabetes Karim Bouzakri 1 , Marina Roques 1 , Philippe Gual 2 , Sophie Espinosa 1 , Fitsum Guebre-Egziabher 1 , Jean-Paul Riou 1 3 , Martine Laville 1 3 , Yannick Le Marchand-Brustel 2 , Jean-François Tanti 2 and Hubert Vidal 1 1 INSERM U449 and CRNHL, IFR 62, R. Laennec Medical Faculty, Lyon, France 2 INSERM U568, Medical Faculty, Nice, France 3 Department of Endocrinology, Diabetology and Nutrition, E. Herriot Hospital, Lyon, France Abstract To understand better the defects in the proximal steps of insulin signaling during type 2 diabetes, we used differentiated human skeletal muscle cells in primary culture. When compared with cells from control subjects, myotubes established from patients with type 2 diabetes presented the same defects as those previously evidenced in vivo in muscle biopsies, including defective stimulation of phosphatidylinositol (PI) 3-kinase activity, decreased association of PI 3-kinase with insulin receptor substrate (IRS)-1 and reduced IRS-1 tyrosine phosphorylation during insulin stimulation. In contrast to IRS-1, the signaling through IRS-2 was not altered. Investigating the causes of the reduced tyrosine phosphorylation of IRS-1, we found a more than twofold increase in the basal phosphorylation of IRS-1 on serine 636 in myotubes from patients with diabetes. Concomitantly, there was a higher basal mitogen-activated protein kinase (MAPK) activity in these cells, and inhibition of the MAPKs with PD98059 strongly reduced the level of serine 636 phosphorylation. These results suggest that IRS-1 phosphorylation on serine 636 might be involved in the reduced phosphorylation of IRS-1 on tyrosine and in the subsequent alteration of insulin-induced PI 3-kinase activation. Moreover, increased MAPK activity seems to play a role in the phosphorylation of IRS-1 on serine residue in human muscle cells. Footnotes Address correspondence and reprint requests to Dr. Marina Roques, INSERM U449, Faculté de Médecine RTH Laennec, F-69370 Lyon Cedex 08, France. E-mail: roques{at}laennec.univ-lyon1.fr . Received for publication 1 August 2002 and accepted in revised form 19 February 2003. K.B. and M.R. contributed equally to this work. ERK, extracellular signal-related kinase; IRS, insulin receptor substrate; MAPK, mitogen-activated protein kinase; PI, phosphatidylinositol. DIABETES</abstract><cop>Alexandria, VA</cop><pub>American Diabetes Association</pub><pmid>12765939</pmid><doi>10.2337/diabetes.52.6.1319</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0003-1782-1318</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0012-1797
ispartof Diabetes (New York, N.Y.), 2003-06, Vol.52 (6), p.1319-1325
issn 0012-1797
1939-327X
language eng
recordid cdi_hal_primary_oai_HAL_hal_04496821v1
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Antibiotics
Biological and medical sciences
Biopsy
Cells, Cultured
Chemical properties
Complications and side effects
Diabetes
Diabetes Mellitus, Type 2
Diabetes Mellitus, Type 2 - metabolism
Evaluation
Fundamental and applied biological sciences. Psychology
Gene Expression Regulation, Enzymologic
Glucose
Health aspects
Hexokinase
Hexokinase - genetics
Humans
Insulin
Insulin Receptor Substrate Proteins
Insulin receptors
Insulin resistance
Kinases
Life Sciences
MAP Kinase Signaling System
MAP Kinase Signaling System - physiology
Metabolism
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 1 - metabolism
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinases
Mitogen-Activated Protein Kinases - metabolism
Muscle, Skeletal
Muscle, Skeletal - metabolism
Muscle, Skeletal - pathology
Muscles
Musculoskeletal system
Phosphatidylinositol
Phosphatidylinositol 3-Kinases
Phosphatidylinositol 3-Kinases - genetics
Phosphatidylinositols
Phosphoproteins
Phosphoproteins - drug effects
Phosphoproteins - metabolism
Phosphorylation
Phosphoserine
Phosphoserine - metabolism
Phosphotyrosine
Phosphotyrosine - metabolism
Physiological aspects
Plasma
Properties
Receptor, Insulin
Receptor, Insulin - drug effects
Receptor, Insulin - metabolism
Receptors
Reference Values
Risk factors
RNA, Messenger
RNA, Messenger - genetics
Serine
Skeletal muscle
Type 2 diabetes
title Reduced Activation of Phosphatidylinositol-3 Kinase and Increased Serine 636 Phosphorylation of Insulin Receptor Substrate-1 in Primary Culture of Skeletal Muscle Cells From Patients With Type 2 Diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T18%3A10%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Reduced%20Activation%20of%20Phosphatidylinositol-3%20Kinase%20and%20Increased%20Serine%20636%20Phosphorylation%20of%20Insulin%20Receptor%20Substrate-1%20in%20Primary%20Culture%20of%20Skeletal%20Muscle%20Cells%20From%20Patients%20With%20Type%202%20Diabetes&rft.jtitle=Diabetes%20(New%20York,%20N.Y.)&rft.au=BOUZAKRI,%20Karim&rft.date=2003-06-01&rft.volume=52&rft.issue=6&rft.spage=1319&rft.epage=1325&rft.pages=1319-1325&rft.issn=0012-1797&rft.eissn=1939-327X&rft.coden=DIAEAZ&rft_id=info:doi/10.2337/diabetes.52.6.1319&rft_dat=%3Cgale_hal_p%3EA182921905%3C/gale_hal_p%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216484654&rft_id=info:pmid/12765939&rft_galeid=A182921905&rfr_iscdi=true